whats the outlook

Well CIBA has gone directly from "exceptional results" to being unworkable. That takes out most of the surface treatment related products.

It makes me wonder what is the outlook for other product areas, particularly those with scant reporting. Areas including dental trials, air conditioning, bone cement, theraputics, and the more recently silenced Commercial Microbiology.

What is Bosignal's likelyhood of success. My hope is largely with the MIC oil and gas product. Based on earlier announcements I expected conclusive lab results by now. Should ConocoPhillips be seen as a step further than Commercial Micobiology? Is their testing a pro-forma simply for independant verification and trial-production, or could their testing blow MIC out of the water?

Biosignal is fast running out of money, and perhaps goodwill.

I would really like a comprehensive investor update right now, and have asked the company when that might be available.